Nanoform Finland
0.66 EUR
+8.20 %
3,702 following
NANOFH
First North Finland
Medical Equipment & Services
Health Care
Overview
Financials & Estimates
Ownership
Dividend
Investor consensus
Valuation
Income statement
Quarter data
Quarter data
Financial statements, revenue, EBIT, valuation metrics, and quarterly estimates for Nanoform Finland
| Q3/24 | Q4/24 | 2024 | Q1/25 | Q2/25 | Q3/25 | Q4/25 | 2025 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | 8.7 | 8.5 | 31.9 | 9.5 | 7.5 | 7.3 | 14.1 | 38.3 |
| EBITDA | -49.6 | -60.9 | -241.0 | -53.5 | -56.6 | -45.7 | -8.9 | -164.6 |
| EBIT | -59.2 | -69.9 | -278.0 | -62.5 | -65.4 | -54.6 | -17.1 | -199.6 |
| EBIT-% | -681.8 % | -826.7 % | -872.4 % | -655.5 % | -877.2 % | -753.5 % | -121.1 % | -520.6 % |
| Profit before taxes | -62.3 | -64.0 | -268.4 | -58.3 | -66.5 | -52.1 | -16.1 | -193.0 |
| Net income | -62.3 | -64.1 | -268.7 | -58.4 | -66.6 | -52.1 | -16.3 | -193.4 |